Photodynamic therapy with methylaminolevulinate 80 mg/g without occlusion improves acne vulgaris

Journal of Drugs in Dermatology

Volumn 9, Issue 11, 2010, Pages 1347-1352

  Bissonnette, Robert ^a   Maari, Catherine ^a   Nigen, Simon ^a   Provost, Nathalie ^a   Bolduc, Chantal ^a  

^a INNOVADERM RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; METHYLAMINOLEVULINATE; UNCLASSIFIED DRUG; VISONAC; AMINOLEVULINIC ACID METHYL ESTER; DRUG DERIVATIVE; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ACNE VULGARIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FACE; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; INFLAMMATION; OCCLUSION; PAIN; PHOTODYNAMIC THERAPY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RED LIGHT; TREATMENT DURATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METHODOLOGY; PAIN ASSESSMENT; PATHOLOGY; PHOTOCHEMOTHERAPY; SINGLE BLIND PROCEDURE;

ACNE VULGARIS; AMINOLEVULINIC ACID; HUMANS; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SINGLE-BLIND METHOD;

EID: 79952112118     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125-143. (Pubitemid 44969292)
2. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006;54:647-651.
3. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: A blinded, randomized, controlled trial. Br J Dermatol. 2006;154:969-976.
4. Horfelt C, Funk J, Frohm-Nilsson M, et al. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: Results of a randomized, controlled study. Br J Dermatol. 2006;155:608-613. (Pubitemid 44215494)
5. Haedersdal M, Togsverd-Bo K, Wiegell SR, et al. Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial. J Am Acad Dermatol. 2008;58:387-394. (Pubitemid 351227447)
6. Guidance for Industry. Acne vulgaris: Developing drugs for treatment. U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research (CDER). September 2005. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM071292.pdf. Accessed September 14, 2010.
7. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183-192. (Pubitemid 30637186)
8. Hong SB, Lee MH. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris. Photodermatol Photoimmunol Photomed. 2005;21:322-325.
9. Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616-622. (Pubitemid 39330886)
10. Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol. 2008;22:267-278. (Pubitemid 351247414)
11. Horfelt C, Stenquist B, Halldin CB, et al. Single low-dose red light is as efficacious as methyl-aminolevulinate - Photodynamic therapy for treatment of acne: Clinical assessment and fluorescence monitoring. Acta Derm Venereol. 2009;89:372-378.
12. Bissonnette R, Sharfaei S, Viau G, et al. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid. Br J Dermatol. 2004;151:653-655. (Pubitemid 39330891)
13. DUSA Press releases. DUSA announces results for phase IIB trial of Levulan R Photodynamic therapy for moderate to severe acne. Available at http://www.dusapharma.com/october-22-2008.html. Accessed September 14, 2010.